Clinical Trial Update: A Safety and Efficacy Study With YM543 in Type 2 Diabetes Mellitus Subjects [Phase 2]

View source ↗

Summary

Phase 2 safety and efficacy data for the investigational compound YM543 in adults with Type 2 diabetes mellitus were reported from a completed study sponsored b…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• YM543

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Diabetes Mellitus Type 2 | Phase 2 | Status: COMPLETED